Testing effectiveness (Phase 2)Study completedNCT01020383
What this trial is testing
Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients
Who this might be right for
Unstable AnginaNon ST Segment Elevation Myocardial Infarction (NSTEMI)Stable Angina (Associated With High Risk PCI)
Ablynx, a Sanofi company 364